457 related articles for article (PubMed ID: 27044334)
1. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury.
Li L; Ni L; Eugenin EA; Heary RF; Elkabes S
Brain Behav Immun; 2019 Aug; 80():328-343. PubMed ID: 30953770
[TBL] [Abstract][Full Text] [Related]
3. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury.
David BT; Ratnayake A; Amarante MA; Reddy NP; Dong W; Sampath S; Heary RF; Elkabes S
Neurobiol Dis; 2013 Jun; 54():194-205. PubMed ID: 23313320
[TBL] [Abstract][Full Text] [Related]
4. Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.
Li L; Ni L; Heary RF; Elkabes S
J Neuroinflammation; 2020 Feb; 17(1):73. PubMed ID: 32098620
[TBL] [Abstract][Full Text] [Related]
5. A toll-like receptor 9 antagonist restores below-level glial glutamate transporter expression in the dorsal horn following spinal cord injury.
Pallottie A; Ratnayake A; Ni L; Acioglu C; Li L; Mirabelli E; Heary RF; Elkabes S
Sci Rep; 2018 Jun; 8(1):8723. PubMed ID: 29880832
[TBL] [Abstract][Full Text] [Related]
6. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
Butchi NB; Du M; Peterson KE
Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
[TBL] [Abstract][Full Text] [Related]
7. A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury.
David BT; Sampath S; Dong W; Heiman A; Rella CE; Elkabes S; Heary RF
J Neurotrauma; 2014 Nov; 31(21):1800-6. PubMed ID: 24936867
[TBL] [Abstract][Full Text] [Related]
8. The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.
Lu C; Ha T; Wang X; Liu L; Zhang X; Kimbrough EO; Sha Z; Guan M; Schweitzer J; Kalbfleisch J; Williams D; Li C
J Am Heart Assoc; 2014 Apr; 3(2):e000629. PubMed ID: 24721797
[TBL] [Abstract][Full Text] [Related]
9. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
10. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
11. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
12. CpG-ODN exerts a neuroprotective effect via the TLR9/pAMPK signaling pathway by activation of autophagy in a neonatal HIE rat model.
Ye L; Feng Z; Doycheva D; Malaguit J; Dixon B; Xu N; Zhang JH; Tang J
Exp Neurol; 2018 Mar; 301(Pt A):70-80. PubMed ID: 29274721
[TBL] [Abstract][Full Text] [Related]
13. The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice.
Zhou Y; Pan J; Peng Q; Dong Z; Deng L; Wang Y
CNS Neurol Disord Drug Targets; 2017; 16(5):624-633. PubMed ID: 28176622
[TBL] [Abstract][Full Text] [Related]
14. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
Molad Y; Pokroy-Shapira E; Carmon V
Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
16. Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival.
Ghouili I; Bahdoudi S; Morin F; Amri F; Hamdi Y; Coly PM; Walet-Balieu ML; Leprince J; Zekri S; Vaudry H; Vaudry D; Castel H; Amri M; Tonon MC; Masmoudi-Kouki O
Mol Neurobiol; 2018 Jun; 55(6):4596-4611. PubMed ID: 28698967
[TBL] [Abstract][Full Text] [Related]
17. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
[TBL] [Abstract][Full Text] [Related]
18. A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.
Li Y; Cao H; Wang N; Xiang Y; Lu Y; Zhao K; Zheng J; Zhou H
Vaccine; 2011 Mar; 29(11):2193-8. PubMed ID: 21036131
[TBL] [Abstract][Full Text] [Related]
19. ADP-Ribosylation Factor 3 Mediates Cytidine-Phosphate-Guanosine Oligodeoxynucleotide-Induced Responses by Regulating Toll-Like Receptor 9 Trafficking.
Wu JY; Kuo CC
J Innate Immun; 2015; 7(6):623-36. PubMed ID: 26067373
[TBL] [Abstract][Full Text] [Related]
20. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
